Prostate cancer is the second most common cancer in men worldwide, and imaging is increasingly used in prostate cancer management. When considering the low specificity of PSA levels and the complications that can arise with systematic biopsies (e.g., urinary symptoms, infection), imaging has a significant role to play as a sensitive and specific non-invasive exam for prostate cancer detection, staging, and monitoring.
Find out more about the use of imaging to evaluate prostate cancer in clinical trials in this 17-page eBook.
Download the eBook to learn: